$1.1B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | PBLS Parabilis Medicines Inc | 6.4M | — | $176M | 16.0% |
| 2 | BEAM Beam Therapeutics Inc | 4.5M | +0.0% | $156M | 14.2% |
| 3 | RAPP Rapport Therapeutics Inc | 3.7M | +0.0% | $155M | 14.1% |
| 4 | SPTX Seaport Therapeutics Inc | 6.3M | — | $137M | 12.4% |
| 5 | ERAS Erasca Inc | 7.1M | +0.0% | $130M | 11.8% |
| 6 | VIR Vir Biotechnology Inc | 12.7M | −1.7% | $129M | 11.8% |
| 7 | MAZE Maze Therapeutics Inc | 4.1M | +0.0% | $123M | 11.2% |
| 8 | LYEL Lyell Immunopharma Inc | 3.2M | +0.0% | $46M | 4.1% |
| 9 | GENB Generate Biomedicines Inc | 1.9M | +0.0% | $33M | 3.0% |
| 10 | TXG 10X Genomics Inc | 217,834 | +0.0% | $8M | 0.8% |
| 11 | BOLD Boundless Bio Inc | 2.7M | — | $7M | 0.6% |
| 12 | GOSS Gossamer Bio Inc | 8.1M | +0.0% | $1M | 0.1% |